Actinomicosis pulmonar en paciente con neumonía eosinófila crónica en tratamiento con omalizumab

Iribarren, Marta Erro; Serrano, Carolina Cisneros; Naranjo, Olga Rajas; Castillo, Elena García

doi:10.1016/j.arbres.2017.06.006

Cited by 4 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To the best of our knowledge, there have been nine patients with pulmonary A. odontolyticus (excluding those with only empyema or pleural mass without lung lesions) [2,3,[16], [17], [18], [19], [20], [21], [22]]. A summary of the reported cases is presented in Table 1.…”

Section: Discussionmentioning

confidence: 99%

Drastically progressive lung cavity lesion caused by Actinomyces odontolyticus in a patient undergoing chemoradiotherapy: A case report and literature review

Matsumoto

Kusakabe

Enomoto

et al. 2019

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

Pulmonary actinomycosis reportedly forms 15% of all cases of actinomycosis, and pulmonary Actinomyces odontolyticus is particularly rare. A 60-year-old man with a hoarse voice was referred to our hospital. Lung squamous cell carcinoma was diagnosed at the clinical tumor-node-metastasis stage of cT2N2M0, and concurrent chemoradiotherapy was initiated. Further, a small cavity was also detected in the left upper lobe, but it was observed. During chemoradiotherapy, the small cavity lesion rapidly increased accompanying infiltration, and administration of short-term antibiotics did not improve the patient's condition. Bronchoscopy did not show any diagnostic results. Although a rapidly progressive malignant lesion could not be excluded and surgical management was considered, resection could not be performed because of the tight adhesion of the mass. Therefore, bronchoscopy was performed again, and the bronchial lavage culture showed a positive smear for the Actinomyces species. Further, using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), the bacteria was identified as A. odontolyticus. After long-term administration of amoxicillin, the lung cavity with infiltration gradually improved. To the best of our knowledge, there have been nine cases of pulmonary A. odontolyticus (excluding those with only empyema or pleural mass without lung lesions), which can occur in immunocompetent patients with persistent lung shadow. None of the cases showed drastic deterioration; therefore, the present case is the first to highlight that A. odontolyticus possibly produce drastically progressive lung cavity lesion. Further, repeated bronchoscopy and MALDI-TOF MS could help to diagnose pulmonary actinomycosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Drastically progressive lung cavity lesion caused by Actinomyces odontolyticus in a patient undergoing chemoradiotherapy: A case report and literature review

Matsumoto

Kusakabe

Enomoto

et al. 2019

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

show abstract

Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele

MacDonald

Mansfield

2022

Respirology Case Reports

View full text Add to dashboard Cite

We present a 43-year-old woman, with a history of allergic bronchopulmonary aspergillosis and a chronic bronchocoele, who was admitted to hospital with an infection of the bronchocoele, progressing to a pulmonary abscess and polymicrobial empyema, following dental extraction and regular Lactobacillus probiotic ingestion. Interval chest imaging following this procedure demonstrated worsening right upper lobe opacities and a right-sided pleural effusion. Bronchoscopies identified copious mucoid secretions and an infected bronchocoele with a right upper lobe airways impaction. Oral cavity organisms including Actinomyces odontolyticus were cultured on bronchial washings. Streptococcus mitis and Lactobacillus rhamnosus were cultured in pleural fluid. Treatment with endoscopic mucoid secretion suctioning; intercostal catheter insertion and therapeutic drainage; and antibiotic, glucocorticoid and anti-IgE therapy resulted in clinical and radiological improvement. Our case illustrates the potential pulmonary complications from oral cavity organisms following tooth extraction and probiotic use in patients with chronic lung disease associated with mucoid lesions and airways obstruction.

show abstract

Metagenomics Approaches in Discovery and Development of New Bioactive Compounds from Marine Actinomycetes

et al. 2019

View full text Add to dashboard Cite

Actinomicosis pulmonar en paciente con neumonía eosinófila crónica en tratamiento con omalizumab

Cited by 4 publications

References 4 publications

Drastically progressive lung cavity lesion caused by Actinomyces odontolyticus in a patient undergoing chemoradiotherapy: A case report and literature review

Drastically progressive lung cavity lesion caused by Actinomyces odontolyticus in a patient undergoing chemoradiotherapy: A case report and literature review

Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele

Metagenomics Approaches in Discovery and Development of New Bioactive Compounds from Marine Actinomycetes

Contact Info

Product

Resources

About